Head and neck cancer represents the term used to describe various malignant tumors that develop in or around the larynx, sinuses, throat, nose, and mouth. These cancers can mimic less extreme conditions, such as cold and sore throat, and the symptoms may comprise a white or a red patch on the gums, tongue, or the lining area of the mouth, a mouth or tongue sore that does not heal on its own, a persistent sore throat, and hoarseness. Standard techniques for diagnosing head and neck malignancies include an endoscopic examination, a physical exam that may be used to check on the oral and nasal cavities, and laboratory testing using urine, blood, and other body samples. Other tests contain CAT scans, MRIs, X-rays, MRIs, and PET scans to view images inside the neck and head. The two preliminary treatment modalities are surgery and radiotherapy.Ask an Analyst for Report Customization with TOC & List of figures: [FURL=https://bit.ly/3KKMPPO]https://bit.ly/3KKMPPO[/FURL]
The escalating prevalence of this tumor, owing to the rising consumption of alcoholic beverages and tobacco-based products, is primarily driving the head and neck cancer market. Besides this, the increasing incidences of infectious diseases (human papillomavirus/Epstein bar virus), nutritional deficiencies, and underlying genetic disorders are further augmenting the market growth. Moreover, the growing popularity of cancer immunotherapy, on account of its efficacy and fewer side effects compared to traditional chemotherapy, is also catalyzing the global market.
Apart from this, the introduction of advanced oncological imaging modalities and technologies to detect infections with enhanced accuracy and the production of vaccines and novel biomarkers by the leading players for identifying potential tumors are acting as significant growth-inducing factors. Furthermore, the elevating regulatory approvals for new immunotherapy drugs and the emerging trend of gene therapy, monoclonal antibodies, antibody-drug conjugates, etc., are expected to bolster the head and neck cancer market in the coming years.
Request a Free Sample Report: [URL=https://www.imarcgroup.com/head-neck-cancer-market/requestsample]https://www.imarcgroup.com/head-neck-cancer-market/requestsample[/URL]
Key Questions Answered in this Report:
How has the head and neck cancer market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the head and neck cancer market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the head and neck cancer market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: [URL=Sales@imarcgroup.com]Sales@imarcgroup.com[/URL]
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800